Article

25-hydroxyvitamin D levels and the risk of mortality in the general population

Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave, Ullmann 615, Bronx, NY 10461, USA.
Archives of internal medicine (Impact Factor: 13.25). 08/2008; 168(15):1629-37. DOI: 10.1001/archinte.168.15.1629
Source: PubMed

ABSTRACT In patients undergoing dialysis, therapy with calcitriol or paricalcitol or other vitamin D agents is associated with reduced mortality. Observational data suggests that low 25-hydroxyvitamin D levels (25[OH]D) are associated with diabetes mellitus, hypertension, and cancers. However, whether low serum 25(OH)D levels are associated with mortality in the general population is unknown.
We tested the association of low 25(OH)D levels with all-cause, cancer, and cardiovascular disease (CVD) mortality in 13 331 nationally representative adults 20 years or older from the Third National Health and Nutrition Examination Survey (NHANES III) linked mortality files. Participant vitamin D levels were collected from 1988 through 1994, and individuals were passively followed for mortality through 2000.
In cross-sectional multivariate analyses, increasing age, female sex, nonwhite race/ethnicity, diabetes, current smoking, and higher body mass index were all independently associated with higher odds of 25(OH)D deficiency (lowest quartile of 25(OH)D level, <17.8 ng/mL [to convert to nanomoles per liter, multiply by 2.496]), while greater physical activity, vitamin D supplementation, and nonwinter season were inversely associated. During a median 8.7 years of follow-up, there were 1806 deaths, including 777 from CVD. In multivariate models (adjusted for baseline demographics, season, and traditional and novel CVD risk factors), compared with the highest quartile, being in the lowest quartile (25[OH]D levels <17.8 ng/mL) was associated with a 26% increased rate of all-cause mortality (mortality rate ratio, 1.26; 95% CI, 1.08-1.46) and a population attributable risk of 3.1%. The adjusted models of CVD and cancer mortality revealed a higher risk, which was not statistically significant.
The lowest quartile of 25(OH)D level (<17.8 ng/mL) is independently associated with all-cause mortality in the general population.

2 Followers
 · 
112 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Vitamin D deficiency is prevalent in many countries, including Germany. Some countries have introduced vitamin D food fortification to address the problem, but such fortification is generally prohibited in Germany. While recent changes in legislation have opened the window to a population-wide introduction of vitamin D food fortification, before it can be implemented in Germany, the strategy must be adapted to the German scenario. This requires gathering detailed insights about German consumers’ perceptions of vitamin D-fortified food and the impact of vitamin D knowledge and health awareness on consumers’ acceptance. We gather information on these issues and identify consumers’ preferred sources of nutritional information. The study shows a high level of acceptance of vitamin D-fortified food among the German population, which indicates good prospects for successful implementation of a vitamin D food fortification program in Germany. Moreover, the study shows that consumers’ health awareness is an essential determinant of their acceptance of vitamin D-fortified food, so informing consumers about the health effects associated with vitamin D could be a viable way to raise their awareness and ensure their acceptance of vitamin D-fortified products. The study also shows that physicians, health insurance companies, and the internet/television are consumers’ preferred sources of nutritional information and should be the central communication channels for an information campaign. These insights will be valuable in developing and implementing an effective vitamin D food fortification program that is suitable for the German scenario.
    Food Quality and Preference 02/2015; 43:53 - 62. DOI:10.1016/j.foodqual.2015.02.011 · 2.73 Impact Factor
  • Annals of internal medicine 01/2011; 154(1):12. DOI:10.7326/0003-4819-154-1-201101040-00003 · 16.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity, type 2 diabetes, and cardiovascular disease (CVD) are the most common preventable causes of morbidity and mortality worldwide. Insulin resistance, which is a shared feature in these conditions, is also strongly linked to the development of polycystic ovary syndrome (PCOS), which is the most common endocrine disease in women of reproductive age and a major cause of infertility. Vitamin D deficiency has reached epidemic proportions worldwide, primarily due to the shift to sedentary, indoor lifestyles and sun avoidance behaviours to protect against skin cancer. In recent years, vitamin D deficiency has been implicated in the aetiology of type 2 diabetes, PCOS and CVD, and has been shown to be associated with their risk factors including obesity, insulin resistance, hypertension, as well as chronic low--grade inflammation. Treating vitamin D deficiency may offer a feasible and cost-effective means of reducing cardiometabolic risk factors at a population level in order to prevent the development of type 2 diabetes and CVD. However, not all intervention studies show that vitamin D supplementation improves these risk factors. Importantly, there is significant heterogeneity in existing studies with regards to doses and drug regimens used, populations studied (i.e. vitamin D deficient or sufficient), and the lengths of supplementation, and only few studies have directly studied the effect of vitamin D on insulin secretion and resistance with the use of clamp methods. Therefore, there is a need for well-designed large scale trials to clarify the role of vitamin D supplementation in the prevention of type 2 diabetes, PCOS, and CVD.
    Minerva endocrinologica 02/2015; · 1.32 Impact Factor

Full-text (2 Sources)

Download
45 Downloads
Available from
Jun 10, 2014

Similar Publications